Liposomal Antioxidants for Protection against Oxidant-Induced Damage
暂无分享,去创建一个
[1] B. Bacon,et al. Iron Toxicity and Chelation Therapy , 2002, International journal of hematology.
[2] P. Ward,et al. Oxidative stress: acute and progressive lung injury , 2010, Annals of the New York Academy of Sciences.
[3] N. Narayanan,et al. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice , 2009, International journal of cancer.
[4] I. Benzie. Evolution of antioxidant defence mechanisms , 2000, European journal of nutrition.
[5] C. Nunes,et al. Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects. , 2010, Chemistry and physics of lipids.
[6] D. Crommelin,et al. Liposomes and biotherapeutics , 1991, Biotherapy.
[7] Teodoro Espinosa-Solares,et al. Macroscopic mass and energy balance of a pilot plant anaerobic bioreactor operated under thermophilic conditions , 2006, Applied biochemistry and biotechnology.
[8] F. Baillet,et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] D. Noto,et al. A novel component of the metabolic syndrome: the oxidative stress. , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[10] C. Cervellati,et al. Oxygen, reactive oxygen species and tissue damage. , 2004, Current pharmaceutical design.
[11] A. Fisher,et al. Peroxiredoxin 6 as an antioxidant enzyme: Protection of lung alveolar epithelial type II cells from H2O2‐induced oxidative stress , 2008, Journal of cellular biochemistry.
[12] B. Ekstrand-Hammarström,et al. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury , 2009, Inhalation toxicology.
[13] J. Crapo,et al. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. , 1984, The Journal of clinical investigation.
[14] V. Muzykantov. Delivery of antioxidant enzyme proteins to the lung. , 2001, Antioxidants & redox signaling.
[15] S. Beg,et al. Bioavailability enhancement of coenzyme Q10: an extensive review of patents. , 2010, Recent patents on drug delivery & formulation.
[16] W. McBride,et al. N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-κB activation , 2002 .
[17] H. Eichler,et al. Kinetics and disposition of fluorescein-labelled liposomes in healthy human subjects , 2004, European Journal of Clinical Pharmacology.
[18] A. Gillissen,et al. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. , 1998, Respiratory medicine.
[19] V. Muzykantov. Targeting of superoxide dismutase and catalase to vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[20] K. Turpaev. Reactive Oxygen Species and Regulation of Gene Expression , 2002, Biochemistry (Moscow).
[21] G. Zeevalk,et al. Liposomal-Glutathione Provides Maintenance of Intracellular Glutathione and Neuroprotection in Mesencephalic Neuronal Cells , 2010, Neurochemical Research.
[22] Elias S. J. Arnér,et al. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.
[23] Z. Drulis-Kawa,et al. Liposomes as delivery systems for antibiotics. , 2010, International journal of pharmaceutics.
[24] I. Grattagliano,et al. Disposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione. , 1995, The Journal of pharmacology and experimental therapeutics.
[25] F. Sarkar,et al. Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. , 2010, Mini reviews in medicinal chemistry.
[26] O. Katare,et al. Liposomal drug delivery systems--clinical applications. , 2005, Acta pharmaceutica.
[27] L. Herzenberg,et al. N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency. , 2007, Current opinion in pharmacology.
[28] J. Kristl,et al. Improvements of cellular stress response on resveratrol in liposomes. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] A. Gabizon,et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Coleman,et al. Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice. , 2007, Atherosclerosis.
[31] Yiyong Huang,et al. Boron-based pronucleophiles in catalytic (asymmetric) C(sp3)–allyl cross-couplings , 2012 .
[32] B. Aggarwal,et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. , 2008, Biochemical pharmacology.
[33] J. V. Sarma,et al. Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury. , 2008, Antioxidants & redox signaling.
[34] S. Matalon,et al. Mitigation of oxidant injury to lung microvasculature by intratracheal instillation of antioxidant enzymes. , 1993, The American journal of physiology.
[35] P. Shek,et al. Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes. , 1995, Journal of drug targeting.
[36] D. D. de Araújo,et al. Stability and local toxicity evaluation of a liposomal prilocaine formulation. , 2008, Journal of liposome research.
[37] M. Traber,et al. Vitamin E, antioxidant and nothing more. , 2007, Free radical biology & medicine.
[38] M. Adamcová,et al. Anthracycline-induced cardiotoxicity. , 2000, Acta medica.
[39] R. Arora,et al. Resveratrol: biologic and therapeutic implications. , 2009, Journal of the cardiometabolic syndrome.
[40] Ricky A. Sharma,et al. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. , 2008, Antioxidants & redox signaling.
[41] P. Shek,et al. Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. , 1995, Biomedical and environmental sciences : BES.
[42] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.
[43] H. Redetzki,et al. Vitamin E and paraquat poisoning. , 1980, Veterinary and human toxicology.
[44] A. Ledwožyw. Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. II. Phospholipids of the lung surfactant. , 1991, Acta physiologica Hungarica.
[45] A. Azzi. Oxidative stress: A dead end or a laboratory hypothesis? , 2007, Biochemical and biophysical research communications.
[46] P. Shek,et al. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. , 2000, Surgery.
[47] Y. Naguib. Antioxidant activities of astaxanthin and related carotenoids. , 2000, Journal of agricultural and food chemistry.
[48] G. Zapata,et al. Alpha-tocopherol protects against oxidative damage to lipids of the rod outer segments of the equine retina. , 2009, Veterinary journal.
[49] Y. Zambito,et al. Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[50] T. Neff,et al. Attenuation of half sulfur mustard gas‐induced acute lung injury in rats , 2006, Journal of applied toxicology : JAT.
[51] M. Keel,et al. Pathophysiology of polytrauma. , 2005, Injury.
[52] N A Kshirsagar,et al. Liposomal drug delivery system from laboratory to clinic. , 2005, Journal of postgraduate medicine.
[53] Anil Kumar,et al. Conundrum and therapeutic potential of curcumin in drug delivery. , 2010, Critical reviews in therapeutic drug carrier systems.
[54] J. Crapo,et al. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. , 1985, Federation proceedings.
[55] V. Muzykantov,et al. PECAM‐targeted delivery of SOD inhibits endothelial inflammatory response , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] R. Fishman,et al. Protective effects of liposome‐entrapped superoxide dismutase on posttraumatic brain edema , 1987, Annals of neurology.
[57] W. Oyen,et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. , 1999, Biochimica et biophysica acta.
[58] Wood Cd,et al. Vitamin E and paraquat poisoning. , 1980 .
[59] Xin Eric Wang,et al. Vitamin E and its function in membranes. , 1999, Progress in lipid research.
[60] T. Allen. Liposomal drug formulations. Rationale for development and what we can expect for the future. , 1998, Drugs.
[61] W. Dröge. Free radicals in the physiological control of cell function. , 2002, Physiological reviews.
[62] H. Yoshiji,et al. Influence of Timing of Administration of Liposome‐encapsulated Superoxide Dismutase on Its Prevention of Acetaminophen‐induced Liver Cell Necrosis in Rats , 1990, Acta pathologica japonica.
[63] R. Kurzrock,et al. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model. , 2009, Anticancer research.
[64] A. Fisher,et al. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. , 2005, Free radical biology & medicine.
[65] Tak Yee Aw,et al. Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.
[66] F. Walther,et al. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. , 1995, The American journal of physiology.
[67] T. Mariani,et al. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. , 2002, Free radical biology & medicine.
[68] P. Shek,et al. Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury. , 1997, Biomedical and environmental sciences : BES.
[69] S. Atiş,et al. N-ACETYLCYSTEINE PROTECTS THE RATS AGAINST PHRENIC NERVE DYSFUNCTION IN SEPSIS , 2006, Shock.
[70] B. Freeman,et al. Augmentation of antioxidant enzymes in vascular endothelium. , 1986, Journal of free radicals in biology & medicine.
[71] M. R. Kumar,et al. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[72] H. Katinger,et al. Topically applied liposome encapsulated superoxide dismutase reduces postburn wound size and edema formation. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[73] Salil K. Das,et al. Protection of half sulfur mustard gas–induced lung injury in guinea pigs by antioxidant liposomes , 2009, Journal of biochemical and molecular toxicology.
[74] G. Kelly,et al. Clinical applications of N-acetylcysteine. , 1998, Alternative medicine review : a journal of clinical therapeutic.
[75] Z. Ďuračková. Some current insights into oxidative stress. , 2010, Physiological research.
[76] H. Schreier,et al. Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. , 1991, Chest.
[77] G. Stark,et al. Functional Consequences of Oxidative Membrane Damage , 2005, The Journal of Membrane Biology.
[78] F. Dosio,et al. From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy , 2003, Tumori.
[79] S. Balu-Iyer,et al. Delivery of therapeutic proteins. , 2010, Journal of pharmaceutical sciences.
[80] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[81] H. Katinger,et al. Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[82] Z. Suntres. Role of antioxidants in paraquat toxicity. , 2002, Toxicology.
[83] T. Tsai,et al. Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. , 2010, International journal of pharmaceutics.
[84] I. Liener,et al. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. , 2015, The American review of respiratory disease.
[85] M. Tsan,et al. Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity. , 1993, Journal of applied physiology.
[86] M. Parnham,et al. Toxicity screening of liposomes. , 1993, Chemistry and physics of lipids.
[87] M. Sentjurc,et al. Local delivery of liposome-encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles. , 2000, Journal of clinical periodontology.
[88] A. Samad,et al. Liposomal drug delivery systems: an update review. , 2007, Current drug delivery.
[89] E. Kairi,et al. Attenuation of ischemic injury by N-acetylcysteine preconditioning of the liver. , 2005, The Journal of surgical research.
[90] N. Das,et al. Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain. , 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[91] C. Winterbourn,et al. Thiol chemistry and specificity in redox signaling. , 2008, Free radical biology & medicine.
[92] J. Jackson,et al. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. , 1989, Journal of applied physiology.
[93] M. Pedersen,et al. Astaxanthin and peridinin inhibit oxidative damage in Fe(2+)-loaded liposomes: scavenging oxyradicals or changing membrane permeability? , 2001, Biochemical and biophysical research communications.
[94] B. Halliwell,et al. Biochemistry of oxidative stress. , 2007, Biochemical Society transactions.
[95] J. Blumberg,et al. Influence of Dietary Vitamin E on the Intermembrane Transfer of α-Tocopherol as Mediated by an α-Tocopherol Binding Protein 1 , 1988 .
[96] V. Muzykantov,et al. Targeting antioxidant and antithrombotic biotherapeutics to endothelium. , 2010, Seminars in thrombosis and hemostasis.
[97] H. Jaeschke,et al. Drug-induced lipid peroxidation in mice--II. Protection against paracetamol-induced liver necrosis by intravenous liposomally entrapped glutathione. , 1982, Biochemical pharmacology.
[98] G. Gregoriadis. Overview of liposomes. , 1991, The Journal of antimicrobial chemotherapy.
[99] A. Georgakilas,et al. The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. , 2010, Chemico-biological interactions.
[100] Siling Wang,et al. Protective effect of Coenzyme Q(10) against oxidative damage in human lens epithelial cells by novel ocular drug carriers. , 2011, International journal of pharmaceutics.
[101] V. Muzykantov,et al. Platelet-Endothelial Cell Adhesion Molecule-1-Directed Endothelial Targeting of Superoxide Dismutase Alleviates Oxidative Stress Caused by Either Extracellular or Intracellular Superoxide , 2007, Journal of Pharmacology and Experimental Therapeutics.
[102] P. Shek,et al. Incorporation of α‐Tocopherol in Liposomes Promotes the Retention of Liposome‐encapsulated Glutathione in the Rat Lung , 1994, The Journal of pharmacy and pharmacology.
[103] M. Foti,et al. Non-phenolic radical-trapping antioxidants , 2015 .
[104] I. Grattagliano,et al. Effect of oral glutathione monoethyl ester and glutathione on circulating and hepatic sulfhydrils in the rat. , 1994, Pharmacology & toxicology.
[105] C. Chow. Biological Functions and Metabolic Fate of Vitamin E Revisited , 2004, Journal of Biomedical Science.
[106] D. Harrison,et al. Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium , 2009, Journal of Pharmacology and Experimental Therapeutics.
[107] P. Chan,et al. Liposome-entrapped superoxide dismutase ameliorates infarct volume in focal cerebral ischaemia. , 1990, Acta neurochirurgica. Supplementum.
[108] M. Anderson,et al. Glutathione Therapy: From Prodrugs to Genes , 1998, Seminars in liver disease.
[109] F. L. Crane,et al. Biochemical Functions of Coenzyme Q10 , 2001, Journal of the American College of Nutrition.
[110] Z. Suntres,et al. Prooxidative effect of copper--metallothionein in the acute cytotoxicity of hydrogen peroxide in Ehrlich ascites tumour cells. , 2006, Toxicology.
[111] L. Smith,et al. Glutathione localization and distribution after intratracheal instillation. Implications for treatment. , 1992, The American review of respiratory disease.
[112] B. Lauterburg,et al. The systemic availability of oral glutathione , 2005, European Journal of Clinical Pharmacology.
[113] J. Beaudeux,et al. Resveratrol bioavailability and toxicity in humans. , 2010, Molecular nutrition & food research.
[114] K. Croft. The Chemistry and Biological Effects of Flavonoids and Phenolic Acids a , 1998, Annals of the New York Academy of Sciences.
[115] S. Yamashita,et al. Where are we with probucol: a new life for an old drug? , 2009, Atherosclerosis.
[116] M. Matsuo,et al. Membrane stabilizing effect of vitamin E: existence of a hydrogen bond between alpha-tocopherol and phospholipids in bilayer liposomes. , 1990, Journal of nutritional science and vitaminology.
[117] K. Jellinger. Basic mechanisms of neurodegeneration: a critical update , 2010, Journal of cellular and molecular medicine.
[118] J. Matsumoto,et al. Further studies of lipid peroxidation in human paraquat poisoning. , 1986, Archives of internal medicine.
[119] S. S. Levinson,et al. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[120] R. Chopra,et al. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics , 2006, Free radical research.
[121] F. Ursini,et al. Prooxidant role of vitamin E in copper induced lipid peroxidation , 1993, FEBS letters.
[122] R. Russell,et al. β-Carotene and Other Carotenoids as Antioxidants , 1999 .
[123] R. N. Chakrabarti,et al. Hepatoprotective Activity of Liposomal Flavonoid against Arsenite-Induced Liver Fibrosis , 2007, Journal of Pharmacology and Experimental Therapeutics.
[124] J. Weinstein,et al. Interactions of liposomes with mammalian cells. , 1978, Annual review of biophysics and bioengineering.
[125] B. Halliwell,et al. Micronutrients: oxidant/antioxidant status , 2001, British Journal of Nutrition.
[126] V. Muzykantov,et al. Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. , 2005, Current pharmaceutical design.
[127] D M Hyde,et al. Synergistic interaction of ozone and respirable aerosols on rat lungs. IV. Protection by quenchers of reactive oxygen species. , 1988, Toxicology.
[128] Vladimir P Torchilin,et al. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. , 2006, Annual review of biomedical engineering.
[129] V. Castranova,et al. Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. , 2007, Toxicology and applied pharmacology.
[130] C. Dejong,et al. Adequate range for sulfur-containing amino acids and biomarkers for their excess: lessons from enteral and parenteral nutrition. , 2006, The Journal of nutrition.
[131] G. Burton. Vitamin E: molecular and biological function , 1994, Proceedings of the Nutrition Society.
[132] T. Minko,et al. Selected contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal alpha-tocopherol. , 2002, Journal of applied physiology.
[133] Abdelwahab Omri,et al. Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. , 2008, International journal of pharmaceutics.
[134] P. Shek,et al. Prophylaxis against lipopolysaccharide-induced acute lung injury by alpha-tocopherol liposomes. , 1998, Critical care medicine.
[135] B. Frei,et al. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? , 2006, Free radical biology & medicine.
[136] B. Ray,et al. Antioxidant liposomes protect against CEES‐induced lung injury by decreasing SAF‐1/MAZ‐mediated inflammation in the guinea pig lung , 2010, Journal of biochemical and molecular toxicology.
[137] J. Crestanello,et al. Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect. , 1996, Surgery.
[138] Abdelwahab Omri,et al. Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries , 2007, Journal of endotoxin research.
[139] P. Shek,et al. TREATMENT OF LPS‐INDUCED TISSUE INJURY: ROLE OF LIPOSOMAL ANTIOXIDANTS , 1996, Shock.
[140] C. Shaw,et al. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death , 1997, Brain Research Reviews.
[141] V. Djordjević. Free radicals in cell biology. , 2004, International review of cytology.
[142] M. Hashida,et al. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives. , 1992, The Journal of pharmacology and experimental therapeutics.
[143] M. Comporti. Three models of free radical-induced cell injury. , 1989, Chemico-biological interactions.
[144] H. Harn,et al. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. , 2006, Life sciences.
[145] W. Stone,et al. Therapeutic uses of antioxidant liposomes , 2004, Molecular biotechnology.
[146] R. Roberts,et al. Tissue vitamin E levels in newborn rabbits after pharmacologic dosing. Influence of dose, dosage form, and route of administration. , 1985, Developmental pharmacology and therapeutics.
[147] Steven R Steinhubl,et al. Why have antioxidants failed in clinical trials? , 2008, The American journal of cardiology.
[148] W. Nau,et al. Phase-dependent lateral diffusion of α-tocopherol in DPPC liposomes monitored by fluorescence quenching. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[149] J. McCord,et al. The evolution of free radicals and oxidative stress. , 2000, The American journal of medicine.
[150] G. D’Andrea. Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided , 2005, CA: a cancer journal for clinicians.
[151] J. Crestanello,et al. Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury. , 1998, The Journal of surgical research.
[152] P. Millea. N-acetylcysteine: multiple clinical applications. , 2009, American family physician.
[153] R. Y. Peng,et al. Improved membrane transport of astaxanthine by liposomal encapsulation. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[154] P. Shek,et al. Pulmonary Uptake of Liposome‐associated α‐Tocopherol Following Intratracheal Instillation in Rats , 1993, The Journal of pharmacy and pharmacology.
[155] Synergistic interaction of ozone and respirable aerosols on rat lungs. II. Synergy between ammonium sulfate aerosol and various concentrations of ozone. , 1986, Toxicology and applied pharmacology.
[156] Elizabeth J Johnson,et al. Carotenoid actions and their relation to health and disease. , 2005, Molecular aspects of medicine.
[157] M. Nucci,et al. Immunogenicity of polyethylene glycol-modified superoxide dismutase and catalase. , 1986, Journal of free radicals in biology & medicine.
[158] Rafael Radi,et al. Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. , 2009, ACS chemical biology.
[159] B. Ye,et al. Liposomal Quercetin Efficiently Suppresses Growth of Solid Tumors in Murine Models , 2006, Clinical Cancer Research.
[160] S. Mabry,et al. Prevention of chronic pulmonary oxygen toxicity in young rats with liposome‐encapsulated catalase administered intratracheally , 1991, Pediatric pulmonology.
[161] N. Hidiroglou,et al. Blood plasma and tissue concentrations of vitamin E in beef cattle as influenced by supplementation of various tocopherol compounds. , 1988, Journal of animal science.
[162] P. Diwan,et al. Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study. , 2000, Pharmaceutica acta Helvetiae.
[163] L. Tamer,et al. Effect of N-Acetylcysteine on Blood and Tissue Lipid Peroxidation in Lipopolysaccharide-Induced Obstructive Jaundice , 2006, Journal of investigative surgery : the official journal of the Academy of Surgical Research.
[164] J. Arunakaran,et al. Role of α-tocopherol on antioxidant status in liver, lung and kidney of PCB exposed male albino rats , 2006 .
[165] F. Baillet,et al. Treatment of radiofibrosis with liposomal superoxide dismutase. Preliminary results of 50 cases. , 1986, Free radical research communications.
[166] E. Postaire,et al. Pharmacokinetics of superoxide dismutase in rats after oral administration. , 1996, Biopharmaceutics & drug disposition.
[167] Y. Barenholz,et al. Local prevention of oxidative stress in the intestinal epithelium of the rat by adhesive liposomes of superoxide dismutase and tempamine. , 2005, Molecular pharmaceutics.
[168] Abdelwahab Omri,et al. The Role of Liposomal Antioxidants in Oxidative Stress , 2006 .
[169] S. Davis,et al. Advances in the Use of Tocols as Drug Delivery Vehicles , 2006, Pharmaceutical Research.
[170] M. Rudnick,et al. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.
[171] A. Stefanov,et al. Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes , 2007, Cardiovascular Toxicology.
[172] P. Shek,et al. Liposomal α-Tocopherol Alleviates the Progression of Paraquat-induced Lung Damage , 1995 .
[173] M. Ahmad,et al. Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.
[174] Makoto Takahashi,et al. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. , 2009, Journal of agricultural and food chemistry.
[175] M. Lean,et al. DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS , 2005, Drug Metabolism and Disposition.
[176] A. Bast,et al. Oxidative Stress and Vascular Function: Implications for Pharmacologic Treatments , 2010, Current hypertension reports.
[177] C. Benz,et al. Future directions of liposome- and immunoliposome-based cancer therapeutics. , 2004, Seminars in oncology.
[178] R. Exner,et al. Therapeutic potential of glutathione. , 2000, Wiener klinische Wochenschrift.
[179] P. Shek,et al. Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione. , 1996, Biochemical pharmacology.
[180] P. Chan,et al. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. , 1990, Stroke.
[181] R. Cooke,et al. Reduction of Oxidative Stress Marker in Lung Fluid of Preterm Infants after Administration of Intra-Tracheal Liposomal Glutathione , 2005, Neonatology.
[182] P. Cullis,et al. Recent advances in liposomal drug-delivery systems. , 1995, Current opinion in biotechnology.
[183] W. De Backer,et al. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. , 2007, Pulmonary pharmacology & therapeutics.
[184] H. Forman,et al. Signaling by the Respiratory Burst in Macrophages , 2001, IUBMB life.